Option Care Health OPCH
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Option Care Health (OPCH) Business Model and Operations Summary
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders among others.
Key Insights
Option Care Health (OPCH) Core Market Data and Business Metrics
Latest Closing Price
$34.95Market Cap
$5.78 BillionPrice-Earnings Ratio
28.41Total Outstanding Shares
164.24 Million SharesTotal Employees
8,088Dividend
No dividendIPO Date
August 15, 1996SIC Description
Services-home Health Care ServicesPrimary Exchange
NASDAQHeadquarters
3000 Lakeside Dr, Bannockburn, IL, 60015
Historical Stock Splits
If you bought 4 shares of OPCH before February 3, 2020, you'd have 1 share today.
| Execution Date | Split Amount |
|---|---|
| February 3, 2020 | 1-for-4 (Reverse Split) |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Financing Activities | $-218.21 Million |
| Net Cash Flow From Investing Activities, Continuing | $-36.47 Million |
| Net Cash Flow From Operating Activities, Continuing | $323.39 Million |
| Net Cash Flow From Operating Activities | $323.39 Million |
| Net Cash Flow From Financing Activities, Continuing | $-218.21 Million |
| Net Cash Flow, Continuing | $68.72 Million |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Selling, General, and Administrative Expenses | $630.25 Million |
| Gross Profit | $1.01 Billion |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0 |
| Nonoperating Income/Loss | $-38.23 Million |
| Revenues | $5.00 Billion |
| Preferred Stock Dividends And Other Adjustments | $0 |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss | $207.89 Million |
| Other Comprehensive Income/Loss Attributable To Parent | $-3.93 Million |
| Other Comprehensive Income/Loss | $207.89 Million |
| Comprehensive Income/Loss Attributable To Parent | $207.89 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Equity | $1.40 Billion |
| Liabilities And Equity | $3.42 Billion |
| Assets | $3.42 Billion |
| Current Assets | $1.32 Billion |
| Other Current Assets | $934.50 Million |
| Wages | $63.03 Million |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||